论文部分内容阅读
为了观察紫外线血液辐射疗法（ＵＢＩ）对急性脑血管病患者的远期预后影响和细胞遗传学远期效应，对３７例经ＵＢＩ治疗的患者和６３例对照组患者进行了为期４．７±０．９年的随访观察；ＵＢＩ组１５例与对照组１５例淋巴细胞染色体畸变（ＣＡ）、淋巴细胞胞质分裂阻断微核（ＣＢＭＮ）对比观察；ＵＢＩ组５例患者治疗前和４．９年后（随访时）ＣＡ作自身比较。结果表明：脑出血、脑梗塞ＵＢＩ组死亡率与对照组比较差异无显著意义（Ｐ均＞０．０５）。脑出血、脑梗塞患者随访时总的生活能力状态分级，ＵＢＩ组与对照组比较，差异均有显著意义（Ｐ＜０．０５）。ＵＢＩ组与对照组ＣＡ、ＣＢＭＮ比较无显著差异（Ｐ均＞０．０５）。ＵＢＩ组５例患者自身ＣＡ对比，差异无显著意义（Ｐ＞０．０５）。结果显示，ＵＢＩ疗法对急性脑血管病患者远期预后有良好的辅助作用。
In order to observe the long-term prognosis and cytogenetic long-term effects of UBI in patients with acute cerebrovascular disease, 37 patients with UBI and 63 controls were enrolled in this study. The duration of UBI was 4.7 ± 0 .9 years of follow-up observation; 15 cases of UBI group and control group, 15 cases of lymphocyte chromosome aberration (CA), lymphocyte cytokinesis and micronuclei (CBMN) comparison; UBI group 5 patients before treatment and 4.9 Years later (at follow-up), CA compared itself. The results showed that there was no significant difference in mortality rate between UBI group and cerebral hemorrhage group (P> 0.05). The total life status of patients with cerebral hemorrhage and cerebral infarction was grading. There was significant difference between UBI group and control group (P <0.05). UBI group and control group CA, CBMN no significant difference (P all> 0.05). UBI group of 5 patients with their own CA contrast, no significant difference (P> 0.05). The results showed that UBI therapy has a good adjuvant effect on the long-term prognosis of patients with acute cerebrovascular disease.